Georg Behrens
  • Department of Clinical Immunology and Rheumatology, Hannover Medical School, Germany
  • Microbiology


M.D., Hannover Medical School, Hannover, Germany, 1995
Ph.D., Department of Clinical Immunology and Transfusion Medicine, Giessen, 1996

Current position

Professor, Department for Clinical Immunology and Rheumatology
Head of the DFG-funded Clinical Research Group KFO 250 at Hannover Medical School, Hannover, Germany

Publications (selected)

  1. Kuhl, A., Banning, C., Marzi, A., Votteler, J., Steffen, I., Bertram, S., Glowacka, I., Konrad, A., Sturzl, M., Guo, J. T., Schubert, U., Feldmann, H., Behrens, G., Schindler, M. and Pohlmann, S. (2011). The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin. J Infect Dis 204 Suppl 3: S850-860.
  2. Behrens, G. M. (2011). Abacavir and myocardial infarctions: the benefit of doubt? AIDS 25(16): 2043-2045.
  3. Prajeeth, C. K., Jirmo, A. C., Krishnaswamy, J. K., Ebensen, T., Guzman, C. A., Weiss, S., Constabel, H., Schmidt, R. E. and Behrens, G. M. (2010). The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens. Eur J Immunol 40(5): 1272-1283.
  4. Kuhl, A., Munch, J., Sauter, D., Bertram, S., Glowacka, I., Steffen, I., Specht, A., Hofmann, H., Schneider, H., Behrens, G. and Pohlmann, S. (2010). Calcium-modulating cyclophilin ligand does not restrict retrovirus release. Nat Med 16(2): 155-156; author reply 157.
  5. Jirmo, A. C., Nagel, C. H., Bohnen, C., Sodeik, B. and Behrens, G. M. (2009). Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1. J Immunol 182(1): 283-292.
  6. Wilson, N. S.*, Behrens, G. M.*, Lundie, R. J.*, Smith, C. M., Waithman, J., Young, L., Forehan, S. P., Mount, A., Steptoe, R. J., Shortman, K. D., de Koning-Ward, T. F., Belz, G. T., Carbone, F. R., Crabb, B. S., Heath, W. R. and Villadangos, J. A. (2006). Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 7(2): 165-172. (*Co-first authorship)